Illumina turns down Roche's $5.7B bid

02/7/2012 | Reuters

Illumina's board rejected Roche's $5.7 billion takeover bid and advised shareholders not to tender their shares to Roche. Illumina said the bid undervalued the gene-sequencing firm. Roche called the offer "full and fair" and said it was ready to enter discussions with Illumina.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC